NAMD Comments on Draft Templates for Documenting Compliance with Mental Health Parity Requirements
CMS recently issued a set of templates and instructional guides to document compliance with mental health and substance...
Benefits
Mental Health and Substance Use Treatment
Medicaid plays a vital role in ensuring access to services for mental health and substance use conditions. As the country’s single largest payer for these services, Medicaid serves as the primary access point for prevention services, inpatient and outpatient treatment, and recovery supports.
Resources
NAMD Responds to CMS’s Request for Comments on Mental Health Parity Compliance
On December 4, NAMD formally commented on CMS's request for comments on mental health parity compliance in Medicaid...
Aligning Medicaid and Behavioral Health in Virginia
Episode 5 of Season 4 of the Medicaid Leadership Exchange discusses cross-sector collaboration for behavioral health in Virginia.
NAMD and the Medicaid Medical Directors Network Urge the DEA to Expand Access to Buprenorphine
On March 31, NAMD and the Medicaid Medical Directors Network submitted comments urging the DEA to expand access...
NAMD Comments on Proposed Rule that Would Align 42 CFR Part 2 with HIPAA
On January 31, NAMD submitted comments on a proposed rule that would align 42 CFR Part 2 with...
How Medicaid is Making a Difference for Kids with Complex Behavioral Health Needs
With an uptick in children and youth requiring specialized inpatient psychiatric care, this blog highlights state Medicaid strategies...
Federal Policy Brief: Cross-Agency Collaboration to Address Behavioral Health Needs
Read NAMD's Federal Policy Brief to learn more about how our federal partners can support cross-agency collaboration.
Federal Policy Briefs: Reducing Disparities in Behavioral Health
This Federal Policy Brief highlights opportunities to close racial disparities in behavioral health conditions and access to treatment.